Dual P2Y1/P2Y12 Purinergic Receptor Antagonists (Shenyang Pharmaceutical University/Shenyang Hinewy Pharmaceutical Technology)

N/A

Report date: 2025/01/26 18:22:06
NME

Base Information

Drug NameDual P2Y1/P2Y12 Purinergic Receptor Antagonists (Shenyang Pharmaceutical University/Shenyang Hinewy Pharmaceutical Technology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2Y purinoceptor 1 antagonistsPurinergic receptor P2Y12 antagonists
TargetsP2Y purinoceptor 1Purinergic receptor P2Y12
Therapy Area/IndicationsArterial thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Hinewy Pharmaceutical Technology Co LtdShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsArterial thrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A